FOLH1 and neoplasm: To improve tumor uptake and potentially reduce off-target uptake, we have evaluated several 68Ga-labeled PSMA-617 derivatives by replacing the 2-naphthylalanine (2-Nal) moiety in PSMA-617 with various aromatic amino acids 10-11.